The Science Behind Pop-Up Shops with Melissa Gonzalez of The Lionesque Group

 

Have you noticed more and more pop-up shops in your neighborhood? Have you wondered how they work or what kind of value they might provide a brand, especially with the ubiquity of e-commerce winning on convenience? We knew it was time to look beyond the shop and dig into the inner-workings; we sat down with Melissa Gonzalez, CEO of The Lionesque Group to break down the science behind seasonal retail offerings.

“There are so many opportunities to learn now with technology integration, so everything from door counters to heat mapping and digital touch screens that monitor, just like online, what you are clicking, but then also sales people and brand ambassadors are an opportunity for qualitative data collection and understanding,” Gonzalez said.

Gonzalez also speaks on why pop-up shops are now more viable than ever, how they can provide crucial quantifiable data, and she shares the story of her most recent client who opened up a shop in the middle of New York City.

“It’s a really great opportunity to then make those learnings and make smarter merchandising and marketing decisions going forward,” Gonzalez said.

For the latest news, videos, and podcasts in the Retail Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @RetailMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More